GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (ASX:IMM) » Definitions » Tax Rate %

Immutep (ASX:IMM) Tax Rate % : 0.00% (As of Jun. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Immutep Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Immutep's Tax Expense for the three months ended in Jun. 2024 was A$0.00 Mil. Immutep's Pre-Tax Income for the three months ended in Jun. 2024 was A$0.00 Mil. Therefore, Immutep's Tax Rate % for the quarter that ended in Jun. 2024 was 0.00%.

Immutep Tax Rate % Historical Data

The historical data trend for Immutep's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immutep Tax Rate % Chart

Immutep Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Immutep Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immutep Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Immutep's Tax Rate % for the fiscal year that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2024 )/Pre-Tax Income (A: Jun. 2024 )
=0/-42.717
=0.00 %

Immutep's Tax Rate % for the quarter that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2024 )/Pre-Tax Income (Q: Jun. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immutep Tax Rate % Related Terms

Thank you for viewing the detailed overview of Immutep's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immutep Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (ASX:IMM) » Definitions » Tax Rate %
Comparable Companies
ASX:BOT ASX:IMU ASX:RAC ASX:CUV ASX:ALA ASX:DXB ASX:LTP ASX:OCC ASX:OPT ASX:EZZ VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
PRRUF:USA IMMP:USA YP1A:Germany YP1B:Germany YP1A:Germany YP1B:Germany
Address
264 George Street, Level 32, Australia Square, Sydney, NSW, AUS, 2000
Website
https://www.immutep.com
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Immutep Headlines

No Headlines